Publications by authors named "Florin Caruntu"

Claim this Profile
T
Ten-Year Follow-Up After 96 Weeks Treatment With Peginterferon Plus Tenofovir in Hepatitis D (HIDIT-II): Improved Clinical Outcome After Combination Therapy.
Cihan Yurdaydin, Julia Kahlhöfer, Florin Alexandru Caruntu, Kendal Yalcin, Selim Gürel

United European Gastroenterol J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency, Severity and Impact of Pegylated Interferon Alpha-Associated Flares in Hepatitis D Infection.
Svenja Hardtke, Cihan Yurdaydin, Florin A Caruntu, Manuela G Curescu, Kendal Yalcin

J Viral Hepat· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety.
Henry L Y Chan, Maria Buti, Young-Suk Lim, Kosh Agarwal, Patrick Marcellin, Florin Caruntu

Am J Gastroenterol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D.
Olympia E Anastasiou, Florin A Caruntu, Manuela G Curescu, Kendal Yalcin, Ulus S Akarca

Liver Int· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trial.
Katja Dinkelborg, Julia Kahlhöfer, Petra Dörge, Cihan Yurdaydin, Svenja Hardtke, Florin Alexandru Caruntu

Liver Int· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reduction.
Olympia E Anastasiou, Cihan Yurdaydin, Benjamin Maasoumy, Svenja Hardtke, Florin Alexandru Caruntu

J Viral Hepat· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study.
Birgit Bremer, Olympia E Anastasiou, Svenja Hardtke, Florin Alexandru Caruntu, Manuela G Curescu

Liver Int· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection.
Eli Zuckerman, Julio A Gutierrez, Douglas E Dylla, Victor de Ledinghen, Andrew J Muir, Florin Caruntu

Clin Gastroenterol Hepatol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial.
Heiner Wedemeyer, Cihan Yurdaydin, Svenja Hardtke, Florin Alexandru Caruntu, Manuela G Curescu

Lancet Infect Dis· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis.
Sang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, Florin A Caruntu, Won Young Tak

Dig Dis Sci· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis.
Sang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, Florin A Caruntu, Won Young Tak

Dig Dis Sci· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary peritoneal tuberculosis, a forgotten localization. Case report.
Natalia Florina Buinoiu, Sabrina Ioana Enache, Bogdan Chirculescu, Octavian Enciu, Alina Elena Barbu, Florin Alexandru Caruntu

Indian J Tuberc· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older.
Anca Trifan, Carol Stanciu, Liana Gheorghe, Speranta Iacob, Manuela Curescu, Florin Alexandru Caruntu

Medicine (Baltimore)· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Life Use of 3 Direct-Acting Antiviral Regimen in a Large Cohort of Patients with Genotype-1b HCV Compensated Cirrhosis.
Liana Gheorghe, Speranta Iacob, Manuela Curescu, Ciprian Brisc, Cristina Cijevschi, Florin Caruntu

J Gastrointestin Liver Dis· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study.
Scott Fung, Peter Kwan, Milotka Fabri, Andrzej Horban, Mijomir Pelemis, Florin A Caruntu

J Hepatol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial.
Peter Ferenci, Florin A Caruntu, Gabriella Lengyel, Diethelm Messinger, Georgios Bakalos

Infect Dis Ther· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clostridium difficile Infection in Hospitalized Cirrhotic Patients with Hepatic Encephalopathy.
Florin Alexandru Căruntu, Valeriu Gheorghiță

J Gastrointestin Liver Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials.
Gregory J Dore, Brian Conway, Yan Luo, Ewa Janczewska, Brygida Knysz, Florin Alexandru Caruntu

J Hepatol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B.
Patrick Marcellin, Sang Hoon Ahn, Xiaoli Ma, Florin A Caruntu, Won Young Tak

Gastroenterology· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis Delta Virus Infection in Romania: Prevalence and Risk Factors.
Liana Gheorghe, Irma Eva Csiki, Speranta Iacob, Cristian Gheorghe, Anca Trifan, Florin Caruntu

J Gastrointestin Liver Dis· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-HDV IgM as a marker of disease activity in hepatitis delta.
Anika Wranke, Benjamin Heidrich, Stefanie Ernst, Beatriz Calle Serrano, Florin Alexandru Caruntu

PLoS One· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine dysfunction in sepsis: a beneficial or deleterious host response?
Valeriu Gheorghiţă, Alina Elena Barbu, Monica Livia Gheorghiu, Florin Alexandru Căruntu

Germs· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.
Peter Ferenci, David Bernstein, Jacob Lalezari, Daniel Cohen, Yan Luo, Florin Alexandru Caruntu

N Engl J Med· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B.
Scott Fung, Peter Kwan, Milotka Fabri, Andrzej Horban, Mijomir Pelemis, Florin A Caruntu

Gastroenterology· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real life boceprevir use in treatment-experienced HCV genotype 1 patients with advanced fibrosis.
Liana Gheorghe, Speranta Iacob, Iulia Simionov, Florin Caruntu, Adriana Motoc

J Gastrointestin Liver Dis· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis